Literature DB >> 32298995

Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients.

Marco Ferrari1, Alessandro Ioppi2, Alberto Schreiber3, Tommaso Gualtieri3, Davide Mattavelli3, Vittorio Rampinelli3, Stefano Taboni3, Michele Tomasoni3, Paolo Bossi4, Alberto Deganello3, Piero Nicolai5.   

Abstract

BACKGROUND: Maxillary sinus cancer is a rare disease with heterogeneous biologic behavior. The pattern of neurovascular invasion is known to be an important prognosticator in head and neck cancers, but has not been studied in maxillary malignancies.
MATERIALS AND METHODS: Patients undergoing surgery-based treatment with curative intent for a malignancy of the maxillary sinus at the Unit of Otorhinolaryngology - Head and Neck Surgery of the University of Brescia between November 2000 and October 2018 were included. A description of the characteristics of the patients, tumors, and treatments has been performed along with uni- and multi-variate analysis of prognostic factors. Tumors were classified based on the presence of perineural (P0/P1) and lymphovascular invasion (V0/V1) in 4 categories: P0V0, P1V0, P0V1, and P1V1.
RESULTS: One hundred-thirty-eight patients were included. Mean age at surgery was 61.0 years. Most patients (60.1%) were affected by non-salivary carcinomas, and most tumors (73.9%) were high-grade cancers. One hundred-seven (77.5%) tumors were classified as pT4. The large majority of patients received bi- or tri-modality treatment. Sixty-three (45.7%) cases were classified as P0V0, 32 (23.2%) as P1V0, 7 (5.1%) as P0V1, and 36 (26.1%) as P1V1. T category, nodal status, and neurovascular invasion were significantly associated with prognosis. Perineural and lymphovascular invasion were associated with the topographical growth of the tumor.
CONCLUSIONS: Maxillary cancer is often diagnosed at an advanced stage and in most cases requires a multimodal approach. Perineural and lymphovascular invasion are frequent and have a different impact on prognosis and topographical extension of the tumor.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32298995     DOI: 10.1016/j.oraloncology.2020.104672

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

1.  Does Reorganization of Clinicopathological Information Improve Prognostic Stratification and Prediction of Chemoradiosensitivity in Sinonasal Carcinomas? A Retrospective Study on 145 Patients.

Authors:  Marco Ferrari; Davide Mattavelli; Alberto Schreiber; Tommaso Gualtieri; Vittorio Rampinelli; Michele Tomasoni; Stefano Taboni; Laura Ardighieri; Simonetta Battocchio; Anna Bozzola; Marco Ravanelli; Roberto Maroldi; Cesare Piazza; Paolo Bossi; Alberto Deganello; Piero Nicolai
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

2.  Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy.

Authors:  Nayuta Tsushima; Satoshi Kano; Takayoshi Suzuki; Hiroshi Idogawa; Daisuke Yoshida; Koichi Yasuda; Manami Otsuka; Hidefumi Aoyama; Akihiro Homma
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-18       Impact factor: 2.503

3.  Navigation-Guided Transnasal Endoscopic Delineation of the Posterior Margin for Maxillary Sinus Cancers: A Preclinical Study.

Authors:  Stefano Taboni; Marco Ferrari; Michael J Daly; Harley H L Chan; Donovan Eu; Tommaso Gualtieri; Ashok R Jethwa; Axel Sahovaler; Andrew Sewell; Wael Hasan; Ilyes Berania; Jimmy Qiu; John de Almeida; Piero Nicolai; Ralph W Gilbert; Jonathan C Irish
Journal:  Front Oncol       Date:  2021-11-11       Impact factor: 6.244

4.  A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma.

Authors:  Mingbin Hu; Xiancai Li; Weiguo Gu; Jinhong Mei; Dewu Liu; Shaoqing Chen
Journal:  Front Oncol       Date:  2021-08-24       Impact factor: 6.244

5.  Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters.

Authors:  Davide Mattavelli; Michele Tomasoni; Marco Ferrari; Alessandra Compagnoni; Alberto Schreiber; Stefano Taboni; Vittorio Rampinelli; Elisa Marazzi; Elena Raffetti; Luca Oscar Redaelli de Zinis; Alberto Deganello; Roberto Maroldi; Paolo Bossi; Cesare Piazza; Piero Nicolai
Journal:  Head Neck       Date:  2022-06-02       Impact factor: 3.821

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.